Plunkett Research Online: Inotiv Inc

INOTIV INC (NOTV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (R.....



Inotiv Inc
Ticker: NOTV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 765 463-4527
Fax: 765 497-1102
Address: 2701 Kent Avenue
West Lafayette, IN 47906 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contract Research Services
Contract Research
Non-Clinical Drug Discovery
Non-Clinical Drug Development Services
Scientific Instruments
Software
1. Siemens USA17,791,100,000
2. IQVIA Holdings Inc14,984,000,000
3. ICON plc8,120,176,000
4. PPD Inc4,681,474,000
5. Syneos Health Inc4,415,777,000
6. Charles River Laboratories International Inc4,129,409,000
7. PRA Health Sciences Inc3,183,365,000
8. PAREXEL International Corporation2,665,000,000
9. Medpace Holdings Inc1,885,842,000
10. BGI Genomics Co Ltd1,286,500,000
13. Inotiv Inc490,739,000
Contacts Description
Robert LeasureCEO/Director/President
Beth TaylorCFO/Senior VP, Divisional
Brennan FreemanChief Accounting Officer/Controller/Vice President, Divisional
John SagartzChief Strategy Officer/Director
John BeattieCOO
Nigel BrownDirector
Michael HarringtonDirector
R. NeffDirector
Terry CoelhoDirector
David LandmanDirector
Adrian HardyExecutive VP
Andrea CastetterGeneral Counsel/Secretary/Senior VP
Jeffrey KruppSenior VP, Divisional
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (R.....
See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202420232022202120202019
Financials
    Revenue490,739,000572,425,000547,656,00089,605,00060,469,00043,616,000
    Cost of Revenue379,568,000406,982,000390,444,00059,449,00042,232,00030,695,000
    Gross Margin % - - - - - -
    R&D Expense - - - 405,000950,000627,000
    Operating Income(82,962,000)(9,240,000)20,251,000(5,618,000)(3,063,000)(153,000)
    Operating Margin % - - - - - -
    SGA Expense97,917,000127,318,00099,086,00033,892,00020,350,00012,447,000
    Net Income(108,445,000)(105,140,000)(337,018,000)10,895,000(4,685,000)(790,000)
    Earnings Per Share-4.19-4.10-13.840.83-0.43-0.08
    Dividends - - - - - -
    Book Value Per Share - - - - - -
    Operating Cash Flow(6,805,000)27,883,000(5,217,000)10,746,0001,290,0001,777,000
    Capital Expenditure22,310,00027,503,00036,300,00012,472,0006,200,0006,878,000
    Free Cash Flow(29,115,000)380,000(41,517,000)(1,726,000)(4,910,000)(5,101,000)
Profitability
    EBITDA(26,758,000)(26,506,000)(273,421,000)14,070,000881,0002,573,000
    Return on Assets % - - - - - -
    Return on Equity % - - - - - -
    Net Margin % - - - - - -
    Assets Turnover - - - - - -
    Financial Leverage - - - - - -
Brands, Divisions and Affiliates Top Salaries
Bioanalytical Systems Inc
NameTitleSalary (US$)Bonus (US$)
Robert LeasureCEO/President800,0000
Beth TaylorCFO/Senior VP, Divisional410,0000
John SagartzChief Strategy Officer400,0000
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: